Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01558232 · ClinicalTrials.gov registry record · NA

A Prospective Study to Evaluate Use of the Tibion Bionic Leg in Sub-Acute Post-stroke Patients

A NA study, sponsored by Tibion Bionics.

Terminated
Registry status
NA
Development phase
10
Enrollment target

NCT01558232: Clinical Trial NA study, sponsored by Tibion Bionics.

NCT01558232 is a NA study that was terminated before completion, run by Tibion Bionics. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01558232, a NA study, was terminated before completion, sponsored by Tibion Bionics.

TERMINATED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The objective of this clinical study is to examine acute changes in stability, force allocation, work, and mobility from using a wearable, portable, battery-operated robotic orthosis (the Tibion Bionic Leg) in subacute post-stroke persons undergoing lower extremity physical therapy.

Primary Outcome

Walking speed (comfortable and fastest possible), in meters per second, as measured by the 10 Meter Walk Test (10 MWT).

Interventions

  • DEVICE Tibion Bionic Leg

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2012-03
Est. Completion 2012-08
Phase NA
Tibion Bionics

3 total trials

Why NCT01558232 stopped before completion

NCT01558232 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Tibion Bionic Leg is the first listed.

NCT01558232 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01558232 about?

NCT01558232 is a clinical study titled "A Prospective Study to Evaluate Use of the Tibion Bionic Leg in Sub-Acute Post-stroke Patients". The objective of this clinical study is to examine acute changes in stability, force allocation, work, and mobility from using a wearable, portable, battery-operated robotic orthosis (the Tibion Bionic Leg) in subacute post-stroke persons undergoing lower extremity physical therapy.

What is the current status of trial NCT01558232?

This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2012-03. Estimated completion is 2012-08.

What interventions are being tested in trial NCT01558232?

The interventions under investigation include: Tibion Bionic Leg (DEVICE).

Who is sponsoring clinical trial NCT01558232?

This trial is sponsored by Tibion Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01558232's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01558232, the US trial registry maintained by the National Library of Medicine. NCT01558232 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.